FDA Orange Book · active-ingredient family
Hexachlorophene
Hexachlorophene is approved in 17 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PRE-OP · NDA 017433
17
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · aerosol, emulsion, soap, solution, sponge
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PRE-OPRLD×2 | DAVIS AND GECK | NDA 017433 | AT | Approved Prior to Jan 1, 1982 | |
| TURGEX | XTTRIUM | NDA 019055 | — | Nov 30, 1984 | |
| SEPTISOL | VESTAL LABS | NDA 017424 | — | Approved Prior to Jan 1, 1982 | |
| TURGEX | XTTRIUM | NDA 018375 | — | Approved Prior to Jan 1, 1982 | |
| HEXA-GERM | HUNTINGTON LABS | NDA 017411 | — | Approved Prior to Jan 1, 1982 | |
| PHISOHEX | SANOFI AVENTIS US | NDA 006882 | — | Approved Prior to Jan 1, 1982 | |
| PHISOHEX | SANOFI AVENTIS US | NDA 008402 | — | Approved Prior to Jan 1, 1982 | |
| SOY-DOME | BAYER PHARMS | NDA 017405 | — | Approved Prior to Jan 1, 1982 | |
| GAMOPHEN | ARBROOK | NDA 006270 | — | Approved Prior to Jan 1, 1982 | |
| DIAL | DIAL | NDA 017421 | — | Approved Prior to Jan 1, 1982 | |
| GERMA-MEDICA×2 | HUNTINGTON LABS | NDA 017412 | — | Approved Prior to Jan 1, 1982 | |
| SEPTI-SOFT | CALGON | NDA 017460 | — | Approved Prior to Jan 1, 1982 | |
| SEPTISOL | VESTAL LABS | NDA 017423 | — | Approved Prior to Jan 1, 1982 | |
| E-Z SCRUB | BECTON DICKINSON | NDA 017452 | — | Approved Prior to Jan 1, 1982 | |
| HEXASCRUB | PROF DSPLS | NDA 018363 | — | Approved Prior to Jan 1, 1982 | |
| PHISO-SCRUB | SANOFI AVENTIS US | NDA 017446 | — | Approved Prior to Jan 1, 1982 | |
| SCRUBTEAM SURGICAL SPONGEBRUSH | 3M | NDA 017413 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Hexachlorophene — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

